Medline has put forward terms for an absolutely massive IPO, which could see the medical device manufacturing and ...

Medline plans to sell 179 million Class A shares at $26 to $30 each. ・Major institutional investors signaled interest in ...

TORONTO, Nov. 12, 2025 /CNW/ - The Woodbridge Company Limited ("Woodbridge") announced today that Michael Medline has been appointed President and Chief Executive Officer, effective January 5, 2026.

The Woodbridge Company Limited announced Wednesday that Michael Medline has been appointed President and Chief Executive Officer, effective January 5, 2026. The company said Medline is a highly ...